These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21806563)

  • 1. Medicare Part D's effect on the under- and overuse of medications: a systematic review.
    Polinski JM; Donohue JM; Kilabuk E; Shrank WH
    J Am Geriatr Soc; 2011 Oct; 59(10):1922-33. PubMed ID: 21806563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare part D and long-term care: a systematic review of quantitative and qualitative evidence.
    Pimentel CB; Lapane KL; Briesacher BA
    Drugs Aging; 2013 Sep; 30(9):701-20. PubMed ID: 23729166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.
    Safran DG; Strollo MK; Guterman S; Li A; Rogers WH; Neuman P
    J Gen Intern Med; 2010 Jan; 25(1):10-7. PubMed ID: 19882193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
    Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
    JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations Between Chronic Disease, Polypharmacy, and Medication-Related Problems Among Medicare Beneficiaries.
    Almodóvar AS; Nahata MC
    J Manag Care Spec Pharm; 2019 May; 25(5):573-577. PubMed ID: 31039057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance.
    Polinski JM; Brookhart MA; Glynn RJ; Schneeweiss S
    J Clin Psychopharmacol; 2012 Feb; 32(1):3-10. PubMed ID: 22198455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of reaching the drug benefit threshold on Medicare members' healthcare utilization during the first year of Medicare Part D.
    Raebel MA; Delate T; Ellis JL; Bayliss EA
    Med Care; 2008 Oct; 46(10):1116-22. PubMed ID: 18815534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review.
    Park YJ; Martin EG
    Health Serv Res; 2017 Oct; 52(5):1685-1728. PubMed ID: 27480577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicare Part D and quality of prescription medication use in older adults.
    Lau DT; Briesacher BA; Touchette DR; Stubbings J; Ng JH
    Drugs Aging; 2011 Oct; 28(10):797-807. PubMed ID: 21970307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.
    Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP
    JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of transitioning to medicare part d drug coverage in seniors dually eligible for medicare and medicaid.
    Shrank WH; Patrick AR; Pedan A; Polinski JM; Varasteh L; Levin R; Liu N; Schneeweiss S
    J Am Geriatr Soc; 2008 Dec; 56(12):2304-10. PubMed ID: 19093930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.
    Donohue JM; Frank RG
    Psychiatr Serv; 2007 Oct; 58(10):1285-91. PubMed ID: 17914004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis.
    Tseng CW; Dudley RA; Chen R; Walensky RP
    JAMA Netw Open; 2020 Apr; 3(4):e202739. PubMed ID: 32286656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
    Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
    Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemia.
    Doshi JA; Li P; Huo H; Pettit AR; Kumar R; Weiss BM; Huntington SF
    Am J Manag Care; 2016 Mar; 22(4 Suppl):s78-86. PubMed ID: 27270157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Prescription Drug Insurance and Health Care Utilization Among Medicare Beneficiaries.
    Alexander GC; Schiman C; Kaestner R
    Med Care Res Rev; 2018 Apr; 75(2):153-174. PubMed ID: 29148319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare beneficiaries' knowledge of and choices regarding Part D, 2005 to the present.
    Polinski JM; Bhandari A; Saya UY; Schneeweiss S; Shrank WH
    J Am Geriatr Soc; 2010 May; 58(5):950-66. PubMed ID: 20406313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-related nonadherence in the Medicare program: the impact of Part D.
    Kennedy JJ; Maciejewski M; Liu D; Blodgett E
    Med Care; 2011 May; 49(5):522-6. PubMed ID: 21430574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.